{"transactions":[{"id":704314,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":29077,"kind":"person","name":"Craver Josiah","position":1,"cik":"0002038400","reported_name":"Craver Josiah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PAO"}}],"security":"Performance-Based Stock Option (right to buy)","published_at":"2026-07-23T20:15:06.000Z","date":"2026-07-21","kind":"grant","planned":false,"acquired":true,"shares":30824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents a performance-based stock option that becomes exercisable, if at all, on the later of (i) the first date on which the average closing price of the Issuer's common stock on the Nasdaq Stock Market over any 30 consecutive calendar-day period equals or exceeds $70.00 (the \"Stock Price Hurdle\") and (ii) the first anniversary of the date of grant, in each case subject to the Reporting Person's continued service with the Issuer as of each such date. If the Stock Price Hurdle is not achieved by the fourth anniversary of the date of grant (the \"Performance Period\"), the option will be forfeited in its entirety."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In the event of a Change in Control (as defined in the Issuer's 2026 Equity Incentive Plan) of the Issuer prior to the end of the Performance Period, the Stock Price Hurdle will be deemed achieved if the per-share consideration payable in the transaction equals or exceeds $70.00 (subject to equitable adjustment). If so deemed achieved, the option will vest in full immediately prior to the consummation of the Change in Control, subject to the Reporting Person's continued service with the Issuer through such time. If the Stock Price Hurdle is not achieved or deemed achieved in connection with the Change in Control, the option will be forfeited in its entirety."}],"balance_after":30824,"derivative":{"exercise_price":28.37,"expiration_date":"2036-07-20","underlying":"Common Stock","underlying_shares":30824},"source":{"system":"sec-edgar","filing":"0002038400-26-000004","document":"form4-07232026_040703.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000203840026000004/form4-07232026_040703.xml","form_type":"4"}},{"id":809254,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":29077,"kind":"person","name":"Craver Josiah","position":1,"cik":"0002038400","reported_name":"Craver Josiah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PFO & PAO"}}],"security":"Stock Option (right to buy)","published_at":"2026-04-14T21:18:25.000Z","date":"2026-04-10","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest and become exercisable on April 10, 2027, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter, such that the option is fully vested on the fourth anniversary of the date of grant, or April 10, 2030, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":80000,"derivative":{"exercise_price":29.89,"expiration_date":"2036-04-09","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0002038400-26-000001","document":"form4-04142026_090421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000203840026000001/form4-04142026_090421.xml","form_type":"4"}},{"id":1268602,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":29077,"kind":"person","name":"Craver Josiah","position":1,"cik":"0002038400","reported_name":"Craver Josiah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-14T23:04:58.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest over a period of four years as follows: 25% of the total number of shares subject to the option shall vest on February 14, 2026, and the remainder will vest 1/48th of total number of shares subject to the option monthly thereafter over the remaining three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":50000,"derivative":{"exercise_price":0.476,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-004226","document":"form4-02142025_110254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000141588925004226/form4-02142025_110254.xml","form_type":"4"}},{"id":1323498,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":29077,"kind":"person","name":"Craver Josiah","position":1,"cik":"0002038400","reported_name":"Craver Josiah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-23T21:15:29.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest on December 1, 2025, subject to the Reporting Person's continuous service with the Issuer as of such date."}],"balance_after":100000,"derivative":{"exercise_price":0.4499,"expiration_date":"2034-12-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-24-030068","document":"form4-12232024_041225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000141588924030068/form4-12232024_041225.xml","form_type":"4"}}]}